期刊文献+

抑制c-raf-1基因对人宫颈癌细胞放射敏感性影响的实验研究

Effect of inhibiting c-raf-1 on radiosensitivity in human cervical carcinoma cell line HeLa
下载PDF
导出
摘要 目的:探讨用反义技术抑制癌基因c-raf-1对宫颈癌细胞(HeLa)放射敏感性的影响。方法:设立空白对照组、c-raf-1正义寡核苷酸组和脂质体组(仅加入等量的脂质体)作对照,用RT-PCR检测宫颈癌细胞处理前后c-raf-1表达水平的变化。用集落形成试验检测各实验组照射后人宫颈癌HeLa细胞株集落形成率,AO/EB荧光染色法检测细胞凋亡率的变化,流式细胞仪测定Bcl-2蛋白的表达。结果:c-raf-1反义寡核苷酸能有效抑制c-raf-1癌基因的表达,经脂质体介导的c-raf-1反义寡核苷酸作用的宫颈癌细胞经60Coγ射线照射后其集落形成率较正义寡核苷酸组及单纯照射组明显下降,而凋亡率明显增加,Bcl-2蛋白的表达显著下调,与对照各组比较有显著差异(P<0.01)。结论:c-raf-1反义寡核苷酸通过抑制c-raf-1基因降低人宫颈癌HeLa细胞放射抗性。其辐射增敏作用可能与c-raf-1反义寡核苷酸抑制了辐射抵抗信号转导途径。 Objective:To explore the effect of inhibiting c-raf-1 by antisense technology on radiosensitivity in human cervical carcinoma cell line HeLa. Methods:There were four groups in the study:control group,lipofectin group, sense oligodexynucleotides(S-ODN) group,antisense oligodexynucleotides(AS-ODN) group. The expression of c-raf-1 was detected by means of RT-PCR,Cellular response to irradiation was evaluated by the colony forming test,Apoptosis was observed by fluorescent staining. Bcl-2 protein expression was determined by flow cytometry. Results:AS-ODN group could significantly decreased the proliferation rate and increasing the apoptosis rate,significantly downregulating the expression of Bcl-2 of irradiated human cervical carcinoma cells, (vs lipofectin group or S-ODN group,P〈0.01). Conclusion:c-raf-1 antisense oligodexynucleotides sensitized the HeLa to ionizing irradiation through decreasing the expression of c-raf-l,which might be related to inhibiting the celluar radiation-resistant signal transduction pathway and increasing the apoptosis rate of HeLa cells.
出处 《重庆医科大学学报》 CAS CSCD 2007年第9期946-950,共5页 Journal of Chongqing Medical University
关键词 人宫颈癌细胞株HeLa C-RAF-1 反义技术 放射敏感性 Human cervical carcinoma cell line HeLa c-raf-1 Antisense technology Radiosensitivity
  • 相关文献

参考文献8

  • 1Zebisch A,Czernilofsky AP,Keri G,et al.Signaling Through RAS-RAF-MEK-ERK:from Basics to Bedside[J].Curr Med Chem,2007; 14(5):601-623.
  • 2吴永忠,任庆兰,李少林.c-af-1反义寡核苷酸转染对人卵巢癌SKOV_3细胞增殖的抑制作用[J].重庆医科大学学报,2006,31(1):19-22. 被引量:1
  • 3Al-Mulla F,Hagan S,Behbehani A,et al.Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients[J].J Clin Oncol,2006; 24(36):5672-5679.
  • 4Gupta AK,Bakanauskas VJ,Cerniglia GJ,et al.The ras radiation resistance pathway[J].Cancer Res,2001;61(10):4278-4282.
  • 5Kasid U.Raf-1 protein kinase,signal transduction,and targeted intervention of radiation response[J].Exp Biol Med (Maywood),2001;226(7):624-625.
  • 6Kasid U,Suy S,Dent P,et al.Activation of raf by ionizing radiation[J].Nature,1996;29(382):813-816.
  • 7Johnes HA,Hahm SM,Bernhard E,et al.Ras inhibitors and radiation therapy[J].Semin Radiat Oncol,2001; 11 (4):328-337.
  • 8Tang WY,Chau SP,Tsang WP,et al.The role of Raf-1 in radiation resistance of human hepatocellular carcinoma Hep G2 cells[J].Oncol Rep,2004; 12(6):1349-1354.

二级参考文献9

  • 1Wadler S.New developments in treatment of ovarian cancer[J].Expert Opin Investig Drugs,2001; 10(6):1167-1 172.
  • 2Harries M,Kaye SB.Recent advances in the treatment of epithelial ovarian cancer[J].Expert Opin Investig Drugs,2001;10(9):1715-1724.
  • 3Ozols Robert F.Future directions in the treatment of ovarian cancer[J].Semin Oncol,2002;29(1 supp1):32-42.
  • 4O' Dwyer PJ,Stevenson JP,Gallagher M,et al.C-raf-1 depletion and tumor responses in patients treated with the c-raf-1antisense oligodeoxynucleotide IsIs 5132 (CGP 68936A)[J].Clin Cancer Res,1999;5 (12):3977-3982.
  • 5Kim CK,Haider KhH,Choi SH.Nonviral vector for efficient gene transfer to human ovarian adenocarcinoma cells[J].Gynecol Oncol,2002;84(1):85-93.
  • 6Stevenson JP,Kang-Shen Yao,Gallagher M,et al.Phase Ⅰclinical pharmacokinetic and pharmacodynamic trial of the c-raf-1 antisense ologonucleotide ISIS 5132 (CGP6984A)[J].J Clin Oncol,1999; 17(7):2227-2236.
  • 7Winer MA,Wadewitz AG,Wolgemuth DJ.Members of the raf gene family exhibit segment-specific patterns of expression in mouse epididymis[J].Mol Reprod Dev,1993;35(1):16-23.
  • 8Cuningham CC,Holmulund JT,Schiller JH,et al.A phase Ⅰtrial of c-raf-1 kinase antisense oligonucleotide ISIS 5132 administered as a continuous intravenous infusion in patients with advanced cancer[J].Clin Cancer Res,2000;6(5):1626-1631.
  • 9Vaughn JP,Iglehart JD,Demirdji S,et al.Antisense DNA downregulation of the erbB-2 oncogene measured by a flow cytometric assay[J].Proc Natl Acad Sci USA,1995;92:8338-8342.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部